Vessi Medical
A new ablative approach for the treatment of non-muscle invasive bladder cancer
Technology Development
Business Development
Revenue
Exited
2017
About
Vessi Medical has developed a new ablative approach for the treatment of non-muscle invasive bladder cancer. The Company uses surface cryotherapy, a treatment that utilizes extreme cold, to freeze and destroy abnormal tissue. Its minimally invasive solution provides an office-based therapeutic alternative to surgery.
Currently, surface cryotherapy is used extensively in many applications, and it has been known to be highly effective in destroying surface lesions.
The Vessi Medical system consists of a standalone console and a disposable catheter that is inserted into the bladder similar to existing intravesical (inside the bladder) techniques.
Market Need
The markets seeks an effective ablative treatment of non-muscle invasive bladder cancer that offers reduced side effects, improved patient outcomes, and lower healthcare costs.
